重庆医学
重慶醫學
중경의학
CHONGQING MEDICAL JOURNAL
2015年
16期
2212-2213,2216
,共3页
徐诣芝%何代英%罗治彬%李静%王琛
徐詣芝%何代英%囉治彬%李靜%王琛
서예지%하대영%라치빈%리정%왕침
单核细胞%淋巴细胞%淋巴瘤 ,B细胞%低危%预后
單覈細胞%淋巴細胞%淋巴瘤 ,B細胞%低危%預後
단핵세포%림파세포%림파류 ,B세포%저위%예후
monocyte%lymphocyte%lymphoma,B cell%low-risk%prognosis
目的:探讨外周血单核细胞绝对计数(AMC)及淋巴细胞绝对计数(ALC)与侵袭性B细胞淋巴瘤低危患者预后的相关性。方法回顾性分析了2003~2013年42例初发侵袭性B细胞淋巴瘤低危患者的AMC、ALC及淋巴细胞/单核细胞比值(LMR)与患者各项临床指标、无进展生存期(PFS)和总生存期(OS)的相关性。结果据ROC曲线划分AMC、ALC、LMR对5年OS影响的界限值分别为475/mm3、1005/mm3和2.1。AMC≥475/mm3、ALC<1005/mm3是 PFS的独立不良因素(RR=4.271、3.023;P=0.01、0.39);AMC≥475/mm3是OS的独立不良因素(RR=4.680;P<0.01)。结论初发时高AMC、低ALC患者预后较差。推测外周血AMC、ALC可能成为侵袭性B细胞淋巴瘤低危患者进一步分层的预后指标。
目的:探討外週血單覈細胞絕對計數(AMC)及淋巴細胞絕對計數(ALC)與侵襲性B細胞淋巴瘤低危患者預後的相關性。方法迴顧性分析瞭2003~2013年42例初髮侵襲性B細胞淋巴瘤低危患者的AMC、ALC及淋巴細胞/單覈細胞比值(LMR)與患者各項臨床指標、無進展生存期(PFS)和總生存期(OS)的相關性。結果據ROC麯線劃分AMC、ALC、LMR對5年OS影響的界限值分彆為475/mm3、1005/mm3和2.1。AMC≥475/mm3、ALC<1005/mm3是 PFS的獨立不良因素(RR=4.271、3.023;P=0.01、0.39);AMC≥475/mm3是OS的獨立不良因素(RR=4.680;P<0.01)。結論初髮時高AMC、低ALC患者預後較差。推測外週血AMC、ALC可能成為侵襲性B細胞淋巴瘤低危患者進一步分層的預後指標。
목적:탐토외주혈단핵세포절대계수(AMC)급림파세포절대계수(ALC)여침습성B세포림파류저위환자예후적상관성。방법회고성분석료2003~2013년42례초발침습성B세포림파류저위환자적AMC、ALC급림파세포/단핵세포비치(LMR)여환자각항림상지표、무진전생존기(PFS)화총생존기(OS)적상관성。결과거ROC곡선화분AMC、ALC、LMR대5년OS영향적계한치분별위475/mm3、1005/mm3화2.1。AMC≥475/mm3、ALC<1005/mm3시 PFS적독립불량인소(RR=4.271、3.023;P=0.01、0.39);AMC≥475/mm3시OS적독립불량인소(RR=4.680;P<0.01)。결론초발시고AMC、저ALC환자예후교차。추측외주혈AMC、ALC가능성위침습성B세포림파류저위환자진일보분층적예후지표。
Objective To investigate the prognostic significance of peripheral blood absolute monocyte/lymphocyte count in low‐risk patients with aggressive B cell lymphoma .Methods Retrospective study was performed in 42 low‐risk patients with ag‐gressive B cell lymphoma approved by histology between 2003 to 2013 .Peripheral blood absolute monocyte count (AMC) ,absolute lymphocyte count (ALC) ,lymphocyte/monocyte(LMR) and the some other clinical characters were estimated .Results The best absolute monocyte/lymphocyte count cut‐offs respectively were 475/mm3 and 1 005/mm3 ,analyzed by receiver operating character‐istic curve .AMC≥475/mm3 and ALC<1 005/mm3 were found to be independent predictors of progress free survival (RR=4 .271 , 3 .023 ;P= 0 .01 ,0 .39);AMC≥475/mm3 was found to be independent predictors of 5‐year overall survival (RR= 4 .680;P<0 .0001) in low‐risk patients with aggressive B cell lymphoma .Conclusion Higher AMC and/or lower ALC are poor prognosis fac‐tors .AMC and ALC may be important prognostic factors of low‐risk patients with aggressive B cell lymphoma .